Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.20.2
Consolidated Statements of Operations - USD ($)
12 Months Ended
Jul. 31, 2020
Jul. 31, 2019
Income Statement [Abstract]    
Revenue
Expenses:    
Research and development 25,096,817 18,445,199
General and administrative 18,312,268 11,971,479
Loss from operations (43,409,085) (30,416,678)
Other income, net 185,052 440,037
Interest expense (5,114) (3,805)
Loss on disposal of property and equipment (703)
Foreign currency exchange gain (loss), net 103,136 (281,473)
Realized loss on sale of securities, net (12,134)
Loss before income taxes (43,126,011) (30,274,756)
Income tax expense (benefit) (872,585) 1,297
Net loss $ (42,253,426) $ (30,276,053)
Basic and diluted net loss per common share $ (2.56) $ (4.29)
Weighted average shares used in computing basic and diluted net loss per common share 16,534,551 7,053,279